Results 281 to 290 of about 208,828 (307)

Clinical pharmacology profile of vorinostat, a histone deacetylase inhibitor

Cancer Chemotherapy and Pharmacology, 2013
Marian Iwamoto, E. Friedman, P. Sandhu, N. Agrawal, E. Rubin, J. Wagner   +5 more
semanticscholar   +1 more source

A phase I study of the oral combination of CI-994, a putative histone deacetylase inhibitor, and capecitabine

Annals of Oncology, 2004
Ta Macek
exaly  

Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model

Osteoarthritis and Cartilage, 2008
Keiichiro Nishida, Toshifumi Ozaki
exaly  

Use of class I histone deacetylase inhibitor romidepsin in combination regimens

Leukemia and Lymphoma, 2016
Chadi Nabhan
exaly  

Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)

Annals of Oncology, 2010
Gerhardt Attard
exaly  

A Histone Deacetylase Inhibitor Enhances Recombinant Adeno-associated Virus-Mediated Gene Expression in Tumor Cells

Molecular Therapy, 2006
尚巳 岡田, Hiroaki Mizukami
exaly  

Phase I study of chidamide (CS055/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas

Cancer Chemotherapy and Pharmacology, 2012
M. Dong, Z. Ning, P. Xing, Jia-lian Xu, H. Cao, G. Dou, Z. Meng, Yuankai Shi, Xianping Lu, F. Feng   +9 more
semanticscholar   +1 more source

The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2

EMBO Journal, 2003
Oliver H Krämer, Ingolf Bach, Martin Göttlicher   +2 more
exaly  

Significant growth suppression of synovial sarcomas by the histone deacetylase inhibitor FK228 in vitro and in vivo

Cancer Letters, 2005
Mamoru Ouchida, Toshifumi Ozaki
exaly  

Antidepressant-Like Effects of the Histone Deacetylase Inhibitor, Sodium Butyrate, in the Mouse

Biological Psychiatry, 2007
Wim Crusio, Schahram Akbarian
exaly